Search results
US challenges ‘bogus’ patents on Ozempic and other drugs in effort to spur competition
ABC 26 New Orleans· 7 days agoWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration target…
Biden White House signals pessimism about election in surprising way
Fox News· 7 days agoNEWYou can now listen to Fox News articles! It’s not just atrocious polls that suggest President Joe...
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
CNBC· 7 days agoThe Federal Trade Commission on Tuesday said it is challenging hundreds of alleged "junk" patents...
Sunday Shows preview: College protests heat up nationwide, Noem faces backlash
The Hill via Yahoo News· 2 days agoThe political tension around the ever-growing pro-Palestinian protests on college campuses will...
Pioneer Natural Resources co-founder will be barred from board in deal for Exxon merger
Dallas Morning News· 5 days agoThe Federal Trade Commission is poised to greenlight Exxon Mobil’s $60 billion purchase of...
FTC Challenges 'Bogus' Patents on Ozempic and Other Drugs
MedPage Today· 6 days agoFederal regulators are challenging patents on 20 brand-name drugs, including the blockbuster...